Science

AddToAny

Google+ Facebook Twitter Twitter

T-acute lymphoblastic leukaemia

Healthcare Science Section Lead in Haematology and Haemostasis Michelle Bolam presents a case study.

Routine monitoring bloods were received into the lab from Rheumatology Outpatients on a 56-year-old female with a clinical history of rheumatoid arthritis. No clinical details were stated.

Full blood count (FBC) results are shown in Table 1 – the patient has leucocytosis, predominantly due to a raised lymphocyte count. The patient’s FBC also generated Q Flags [generated from the Interpretive Programme (IP) messages from the XN-Series software] shown in Table 2. One flag of note was the Blast/Abn_lymphocytes? flag. This flag is triggered by the WDF channel when the analyser suspects a malignant condition based on the WDF scattergram, therefore a blood film was made to investigate both the lymphocytosis and the Blast/Abn_lymphocytes? flag.

Click here to read the full article.

Image credit | Michelle Bolam

 

Related Articles

girl computer_CREDIT_shutterstock-58872785

Gamification in biomedical science education

Senior Lecturer in Biomedical Science Jen May outlines the successful implementation of scenario-based learning software.

web_blood-testing_credit_istock-1384651794.png

SPONSORED: The power of automated gel-based ID-cards in routine immunohematology workflows

Immuno-haematology assays are pivotal to the carrying out of blood grouping, antibody screening and transfusions, and represent a critically time-dependent stage in the patient management pathway.

Technician holding a blood sample ready for testing with other human medical samples in the background.-Image credit - Science-Photo-Library-f0243823

Machine learning tool to detect cancer via liquid biopsy

US researchers have developed and tested an innovative machine-learning approach that could one day enable the earlier detection of cancer in patients by using smaller blood draws.

multiple myelomatosis-CREDIT-Science Photo Library-m132099

IBMS research grants

We look at the work of Dr Mosavar Farahani who received an IBMS Research Grant in 2023 to help fund her work on disease progression and skeletal complications in multiple myeloma.

Top